Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mélissa Beaudoin

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Sante Mentale Au Quebec|December 10, 2024
[An integrative review documenting creativity in the utilization of digital health and artificial intelligence at the Institut universitaire en santé mentale de Montréal]Alexandre Hudon, Mélissa Beaudoin
Genome Medicine|January 22, 2015
Comparison of DNA methylation profiles in human fetal and adult red blood cell progenitorsSamuel Lessard, Mélissa Beaudoin, Karim Benkirane, et al.
Journal of Personalized Medicine|March 29, 2023
Changes in Quality of Life in Treatment-Resistant Schizophrenia Patients Undergoing Avatar Therapy: A Content AnalysisMélissa Beaudoin, Stephane Potvin, Kingsada Phraxayavong, et al.
Journal of Cell Science|April 23, 2011
Stochastic and reversible aggregation of mRNA with expanded CUG-triplet repeatsEmmanuelle Querido, Franck Gallardo, Mélissa Beaudoin, et al.
Journal of Personalized Medicine|December 23, 2023
Enhancing Predictive Power: Integrating a Linear Support Vector Classifier with Logistic Regression for Patient Outcome Prognosis in Virtual Reality Therapy for Treatment-Resistant SchizophreniaAlexandre Hudon, Mélissa Beaudoin, Kingsada Phraxayavong, et al.
Journal of Personalized Medicine|May 27, 2023
Unsupervised Machine Learning Driven Analysis of Verbatims of Treatment-Resistant Schizophrenia Patients Having Followed Avatar TherapyAlexandre Hudon, Mélissa Beaudoin, Kingsada Phraxayavong, et al.
JMIR Bioinformatics and Biotechnology|November 15, 2024
Exploring the Intersection of Schizophrenia, Machine Learning, and Genomics: Scoping ReviewAlexandre Hudon, Mélissa Beaudoin, Kingsada Phraxayavong, et al.
Schizophrenia (Heidelberg, Germany)|March 22, 2022
Prediction of quality of life in schizophrenia using machine learning models on data from Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trialMélissa Beaudoin, Alexandre Hudon, Charles-Edouard Giguère, et al.
Journal of Personalized Medicine|June 27, 2024
The Relationship between Sense of Presence, Emotional Response, and Clinical Outcomes in Virtual Reality-Based Therapy for Treatment-Resistant Schizophrenia: An Exploratory Correlational StudyElischa Augustin, Mélissa Beaudoin, Sabrina Giguère, et al.
Human Molecular Genetics|February 13, 2018
14q32 and let-7 microRNAs regulate transcriptional networks in fetal and adult human erythroblastsSamuel Lessard, Mélissa Beaudoin, Stuart H Orkin, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Sante Mentale Au Quebec|December 10, 2024
[An integrative review documenting creativity in the utilization of digital health and artificial intelligence at the Institut universitaire en santé mentale de Montréal]Alexandre Hudon, Mélissa Beaudoin
Genome Medicine|January 22, 2015
Comparison of DNA methylation profiles in human fetal and adult red blood cell progenitorsSamuel Lessard, Mélissa Beaudoin, Karim Benkirane, et al.
Journal of Personalized Medicine|March 29, 2023
Changes in Quality of Life in Treatment-Resistant Schizophrenia Patients Undergoing Avatar Therapy: A Content AnalysisMélissa Beaudoin, Stephane Potvin, Kingsada Phraxayavong, et al.
Journal of Cell Science|April 23, 2011
Stochastic and reversible aggregation of mRNA with expanded CUG-triplet repeatsEmmanuelle Querido, Franck Gallardo, Mélissa Beaudoin, et al.
Journal of Personalized Medicine|December 23, 2023
Enhancing Predictive Power: Integrating a Linear Support Vector Classifier with Logistic Regression for Patient Outcome Prognosis in Virtual Reality Therapy for Treatment-Resistant SchizophreniaAlexandre Hudon, Mélissa Beaudoin, Kingsada Phraxayavong, et al.
Journal of Personalized Medicine|May 27, 2023
Unsupervised Machine Learning Driven Analysis of Verbatims of Treatment-Resistant Schizophrenia Patients Having Followed Avatar TherapyAlexandre Hudon, Mélissa Beaudoin, Kingsada Phraxayavong, et al.
JMIR Bioinformatics and Biotechnology|November 15, 2024
Exploring the Intersection of Schizophrenia, Machine Learning, and Genomics: Scoping ReviewAlexandre Hudon, Mélissa Beaudoin, Kingsada Phraxayavong, et al.
Schizophrenia (Heidelberg, Germany)|March 22, 2022
Prediction of quality of life in schizophrenia using machine learning models on data from Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trialMélissa Beaudoin, Alexandre Hudon, Charles-Edouard Giguère, et al.
Journal of Personalized Medicine|June 27, 2024
The Relationship between Sense of Presence, Emotional Response, and Clinical Outcomes in Virtual Reality-Based Therapy for Treatment-Resistant Schizophrenia: An Exploratory Correlational StudyElischa Augustin, Mélissa Beaudoin, Sabrina Giguère, et al.
Human Molecular Genetics|February 13, 2018
14q32 and let-7 microRNAs regulate transcriptional networks in fetal and adult human erythroblastsSamuel Lessard, Mélissa Beaudoin, Stuart H Orkin, et al.
Pageof 4